Predictors of Successful Weight Loss in Extremely Obese Individuals Undergoing Roux-en-Y Gastric Bypass Surgery.

IF 4.7 Q1 ENDOCRINOLOGY & METABOLISM
Sophia Helena Camargos Moreira, Jacqueline Isaura Alvarez-Leite, Renan Pedra Souza, Giulia Carregal Resmini, Cristina Maria Mendes Resende, Luiz de Marco, Luciana Bastos-Rodrigues
{"title":"Predictors of Successful Weight Loss in Extremely Obese Individuals Undergoing Roux-en-Y Gastric Bypass Surgery.","authors":"Sophia Helena Camargos Moreira, Jacqueline Isaura Alvarez-Leite, Renan Pedra Souza, Giulia Carregal Resmini, Cristina Maria Mendes Resende, Luiz de Marco, Luciana Bastos-Rodrigues","doi":"10.7570/jomes23067","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Roux-en-Y gastric bypass (RYGB) is a standard treatment for severe obesity, but some patients do not achieve the expected success in weight loss. The aim of this study was to evaluate possible predictors of weight loss after RYGB.</p><p><strong>Methods: </strong>Sixty-three patients were included. Pre- and postoperative data were collected from medical records, including comorbidities, anthropometry, energy/macronutrient intake, and physical activity level (PAL). Variants in the brain-derived neurotrophic factor (<i>BDNF; rs6265</i>) and lysophospholipase like 1 (<i>LYPLAL</i>1; <i>rs4846567</i>) genes were investigated. Excess weight loss (EWL) >50% was considered to be successful weight loss (SWL). Logistic regression models were used to verify predictor variables.</p><p><strong>Results: </strong>Participants' median preoperative body mass index (BMI) was 53 kg/m<sup>2</sup> (interquartile range, 46 to 58). At 12 and 24 months after surgery, EWL was 63% and 67%, and the failure rate was 19% and 16%, respectively. The individuals with insufficient weight loss (IWL) after 12 months had higher preoperative weight, BMI, and overweight. At 24 months, lowest frequency of individuals with SWL in the first year was found in the IWL group. No significant differences were found between the groups in dietary intake and PAL. In the logistic regression, high initial BMI was a predictor of the worst response in both periods, and high initial total weight loss was a predictor of a better response at 24 months. The polymorphism analysis did not show differences between groups in either gene.</p><p><strong>Conclusion: </strong>Lower preoperative BMI and greater weight loss at 12 months were predictors of SWL after RYGB.</p>","PeriodicalId":45386,"journal":{"name":"Journal of Obesity & Metabolic Syndrome","volume":" ","pages":""},"PeriodicalIF":4.7000,"publicationDate":"2024-10-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Obesity & Metabolic Syndrome","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.7570/jomes23067","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"ENDOCRINOLOGY & METABOLISM","Score":null,"Total":0}
引用次数: 0

Abstract

Background: Roux-en-Y gastric bypass (RYGB) is a standard treatment for severe obesity, but some patients do not achieve the expected success in weight loss. The aim of this study was to evaluate possible predictors of weight loss after RYGB.

Methods: Sixty-three patients were included. Pre- and postoperative data were collected from medical records, including comorbidities, anthropometry, energy/macronutrient intake, and physical activity level (PAL). Variants in the brain-derived neurotrophic factor (BDNF; rs6265) and lysophospholipase like 1 (LYPLAL1; rs4846567) genes were investigated. Excess weight loss (EWL) >50% was considered to be successful weight loss (SWL). Logistic regression models were used to verify predictor variables.

Results: Participants' median preoperative body mass index (BMI) was 53 kg/m2 (interquartile range, 46 to 58). At 12 and 24 months after surgery, EWL was 63% and 67%, and the failure rate was 19% and 16%, respectively. The individuals with insufficient weight loss (IWL) after 12 months had higher preoperative weight, BMI, and overweight. At 24 months, lowest frequency of individuals with SWL in the first year was found in the IWL group. No significant differences were found between the groups in dietary intake and PAL. In the logistic regression, high initial BMI was a predictor of the worst response in both periods, and high initial total weight loss was a predictor of a better response at 24 months. The polymorphism analysis did not show differences between groups in either gene.

Conclusion: Lower preoperative BMI and greater weight loss at 12 months were predictors of SWL after RYGB.

接受 Roux-en-Y 胃旁路手术的极度肥胖者成功减重的预测因素。
背景:Roux-en-Y胃旁路术(RYGB)是治疗重度肥胖症的标准方法,但有些患者的减肥效果并不尽如人意。本研究旨在评估 RYGB 术后体重减轻的可能预测因素:方法:共纳入 63 名患者。从医疗记录中收集了术前和术后数据,包括合并症、人体测量、能量/微量元素摄入和体力活动水平(PAL)。调查了脑源性神经营养因子(BDNF;rs6265)和溶血磷脂酶样 1(LYPLAL1;rs4846567)基因的变异。超重(EWL)>50% 被认为是成功减重(SWL)。采用逻辑回归模型验证预测变量:结果:参与者术前体重指数(BMI)的中位数为 53 kg/m2(四分位间范围为 46 至 58)。术后 12 个月和 24 个月,EWL 分别为 63% 和 67%,失败率分别为 19% 和 16%。12 个月后体重减轻不足(IWL)者的术前体重、体重指数和超重率均较高。24 个月后,IWL 组在第一年出现 SWL 的频率最低。各组在饮食摄入量和 PAL 方面无明显差异。在逻辑回归中,初始体重指数(BMI)高是两个阶段中反应最差的预测因素,而初始总体重减轻率高则是 24 个月时反应较好的预测因素。多态性分析未显示出两组基因之间的差异:结论:术前体重指数较低和 12 个月时体重减轻较多是 RYGB 术后 SWL 的预测因素。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Journal of Obesity & Metabolic Syndrome
Journal of Obesity & Metabolic Syndrome ENDOCRINOLOGY & METABOLISM-
CiteScore
8.30
自引率
9.60%
发文量
39
审稿时长
19 weeks
期刊介绍: The journal was launched in 1992 and diverse studies on obesity have been published under the title of Journal of Korean Society for the Study of Obesity until 2004. Since 2017, volume 26, the title is now the Journal of Obesity & Metabolic Syndrome (pISSN 2508-6235, eISSN 2508-7576). The journal is published quarterly on March 30th, June 30th, September 30th and December 30th. The official title of the journal is now "Journal of Obesity & Metabolic Syndrome" and the abbreviated title is "J Obes Metab Syndr". Index words from medical subject headings (MeSH) list of Index Medicus are included in each article to facilitate article search. Some or all of the articles of this journal are included in the index of PubMed, PubMed Central, Scopus, Embase, DOAJ, Ebsco, KCI, KoreaMed, KoMCI, Science Central, Crossref Metadata Search, Google Scholar, and Emerging Sources Citation Index (ESCI).
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信